Medistep Healthcare Financials
NSE: MEDISTEP
₹21.50
₹0.00 (0.00%)As on 18-Sep-2026 14:42IST
Market cap
₹31 Cr
Revenue (TTM)
₹50 Cr
P/E Ratio
5.1
P/B Ratio
0.8
Div. Yield
0 %
Income Statement (₹ Cr) |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
49.65
|
31.62
|
--
|
--
|
--
|
--
|
|||||
|
Total Income
|
49.66
|
31.63
|
--
|
--
|
--
|
--
|
|||||
|
Total Expenditure
|
44.04
|
27.65
|
--
|
--
|
--
|
--
|
|||||
|
EBITDA
|
5.61
|
3.96
|
--
|
--
|
--
|
--
|
|||||
|
Depreciation
|
0.03
|
0.02
|
--
|
--
|
--
|
--
|
|||||
|
EBIT
|
5.58
|
3.94
|
--
|
--
|
--
|
--
|
|||||
|
Interest
|
0.04
|
0.06
|
--
|
--
|
--
|
--
|
|||||
|
Other Income
|
0.00
|
0.01
|
--
|
--
|
--
|
--
|
|||||
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
5.54
|
3.89
|
--
|
--
|
--
|
--
|
|||||
|
Provision for Tax
|
1.39
|
0.98
|
--
|
--
|
--
|
--
|
|||||
|
Profit after Tax
|
4.14
|
2.91
|
--
|
--
|
--
|
--
|
Liabilities (₹ Cr) |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
16.83
|
11.69
|
--
|
--
|
--
|
--
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
0.01
|
0.07
|
--
|
--
|
--
|
--
|
|||||
|
Current Liabilities
|
6.13
|
3.19
|
--
|
--
|
--
|
--
|
|||||
|
Total Liabilities
|
22.99
|
14.96
|
--
|
--
|
--
|
--
|
Assets (₹ Cr) |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
0.13
|
0.16
|
--
|
--
|
--
|
--
|
|||||
|
Current Assets
|
22.85
|
14.79
|
--
|
--
|
--
|
--
|
|||||
|
Total Assets
|
22.99
|
14.96
|
--
|
--
|
--
|
--
|
|||||
|
Total Debt*
|
0.64
|
0.33
|
--
|
--
|
--
|
--
|
|||||
|
Net Current Assets
|
16.71
|
11.60
|
--
|
--
|
--
|
--
|
|||||
|
Contingent Liabilities
|
--
|
--
|
--
|
--
|
--
|
--
|
Cashflow (₹ Cr) |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
0.02
|
-7.11
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-0.15
|
--
|
--
|
--
|
--
|
|||||
|
Cash from Financing Activities
|
1.28
|
7.24
|
--
|
--
|
--
|
--
|
|||||
|
Net Cash Inflow / Outflow
|
1.30
|
-0.02
|
--
|
--
|
--
|
--
|
Financials Ratios |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
3.96
|
2.97
|
--
|
--
|
--
|
--
|
|||||
|
Cash EPS (₹)
|
3.99
|
2.99
|
--
|
--
|
--
|
--
|
|||||
|
Adjusted Book Value (₹)
|
16.09
|
11.93
|
--
|
--
|
--
|
--
|
|||||
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share (₹)
|
0.02
|
-14.51
|
--
|
--
|
--
|
--
|
|||||
|
Free Cash Flow per Share (₹)
|
-1.34
|
-16.94
|
--
|
--
|
--
|
--
|
Profitability Ratios |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
37.86
|
32.90
|
--
|
--
|
--
|
--
|
|||||
|
ROE (%)
|
29.06
|
24.92
|
--
|
--
|
--
|
--
|
|||||
|
ROA (%)
|
21.85
|
19.49
|
--
|
--
|
--
|
--
|
|||||
|
EBIT Margin (%)
|
11.23
|
12.47
|
--
|
--
|
--
|
--
|
|||||
|
Net Margin (%)
|
8.35
|
9.21
|
--
|
--
|
--
|
--
|
|||||
|
Cash Profit Margin (%)
|
8.41
|
9.28
|
--
|
--
|
--
|
--
|
Growth Ratios |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
57.06
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EBIT Growth (%)
|
41.48
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Net Profit Growth (%)
|
42.24
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EPS Growth (%)
|
33.18
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Book Value Growth (%)
|
44.00
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
1.74
|
1.31
|
--
|
--
|
--
|
--
|
|||||
|
Close Price (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
High Price (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Low Price (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Market Cap (₹ Cr)
|
--
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.04
|
0.03
|
--
|
--
|
--
|
--
|
|||||
|
Short term debt to equity ratio
|
0.04
|
0.00
|
--
|
--
|
--
|
--
|
|||||
|
Current Ratio
|
3.73
|
4.64
|
--
|
--
|
--
|
--
|
|||||
|
Quick Ratio
|
3.55
|
4.35
|
--
|
--
|
--
|
--
|
|||||
|
Interest Coverage
|
127.74
|
66.22
|
--
|
--
|
--
|
--
|
Operating Efficiency Ratios |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
40.51
|
43.49
|
--
|
--
|
--
|
--
|
|||||
|
Asset Turnover
|
2.62
|
2.11
|
--
|
--
|
--
|
--
|
|||||
|
Receivable days
|
124.47
|
158.76
|
--
|
--
|
--
|
--
|
|||||
|
Inventory Days
|
7.44
|
10.72
|
--
|
--
|
--
|
--
|
|||||
|
Payable days
|
16.20
|
18.80
|
--
|
--
|
--
|
--
|
|||||
|
Cash Conversion Cycle
|
115.71
|
150.68
|
--
|
--
|
--
|
--
|